The role of eicosanoids in renal diseases - potential therapeutic possibilities
Eicosanoids are biologically active molecules that are created in the process of oxidation of arachidonic acid (AA) which is a constituent of the cell membrane phospholipids. Throughout the years it was evidenced by experiments that the lipid and lipid-derived metabolites play an important role in physiological and pathological processes in the kidneys. They are being considered as biomarkers in detecting acute kidney injury, nephrotoxicity, glomerulonephritis and early stages of diabetic nephropathy because of their participation in inflammatory processes and in oxidative stress. They might be also considered as potential novel targets of therapy. However, the role of eicosanoids is still not fully clear and needs to be explored in future studies. In this brief review, studies on the role of eicosanoids in physiological and pathological conditions, e.g. acute kidney injury (AKI) and chronic kidney disease (CKD), and in different renal replacement therapies, including kidney transplantation, are being discussed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
|---|---|
| Enthalten in: |
Acta biochimica Polonica - 65(2018), 4 vom: 19. Nov., Seite 479-486 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fijałkowski, Maciej [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
27YG812J1I |
|---|
| Anmerkungen: |
Date Completed 25.03.2019 Date Revised 25.03.2019 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.18388/abp.2018_2609 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM290833175 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM290833175 | ||
| 003 | DE-627 | ||
| 005 | 20231225065554.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18388/abp.2018_2609 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0969.xml |
| 035 | |a (DE-627)NLM290833175 | ||
| 035 | |a (NLM)30451244 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fijałkowski, Maciej |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The role of eicosanoids in renal diseases - potential therapeutic possibilities |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.03.2019 | ||
| 500 | |a Date Revised 25.03.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Eicosanoids are biologically active molecules that are created in the process of oxidation of arachidonic acid (AA) which is a constituent of the cell membrane phospholipids. Throughout the years it was evidenced by experiments that the lipid and lipid-derived metabolites play an important role in physiological and pathological processes in the kidneys. They are being considered as biomarkers in detecting acute kidney injury, nephrotoxicity, glomerulonephritis and early stages of diabetic nephropathy because of their participation in inflammatory processes and in oxidative stress. They might be also considered as potential novel targets of therapy. However, the role of eicosanoids is still not fully clear and needs to be explored in future studies. In this brief review, studies on the role of eicosanoids in physiological and pathological conditions, e.g. acute kidney injury (AKI) and chronic kidney disease (CKD), and in different renal replacement therapies, including kidney transplantation, are being discussed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a Eicosanoids |2 NLM | |
| 650 | 7 | |a Arachidonic Acid |2 NLM | |
| 650 | 7 | |a 27YG812J1I |2 NLM | |
| 700 | 1 | |a Stępniewska, Joanna |e verfasserin |4 aut | |
| 700 | 1 | |a Domański, Maciej |e verfasserin |4 aut | |
| 700 | 1 | |a Ciechanowski, Kazimierz |e verfasserin |4 aut | |
| 700 | 1 | |a Golembiewska, Edyta |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta biochimica Polonica |d 1955 |g 65(2018), 4 vom: 19. Nov., Seite 479-486 |w (DE-627)NLM00003651X |x 1734-154X |7 nnns |
| 773 | 1 | 8 | |g volume:65 |g year:2018 |g number:4 |g day:19 |g month:11 |g pages:479-486 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18388/abp.2018_2609 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 65 |j 2018 |e 4 |b 19 |c 11 |h 479-486 | ||